Hangzhou Alltest Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	920.38	1,318	1,982	2,179
Trading Asset Securities	-	1,657	1,471	1,833	780.2
Cash & Short-Term Investments	2,459	2,578	2,789	3,815	2,960
Cash Growth	-4.62%	-7.57%	-26.89%	28.90%	322.40%
Accounts Receivable	-	125.12	100.87	138.66	208.2
Other Receivables	-	6.67	8.18	10.35	67.4
Receivables	-	131.79	109.05	149.02	275.6
Inventory	-	160.32	188.59	193.66	383.84
Prepaid Expenses	-	0.71	11.65	2.15	8.19
Other Current Assets	-	94.75	63.24	29.63	41.03
Total Current Assets	-	2,965	3,161	4,189	3,668
Property, Plant & Equipment	-	903.44	759.8	317.14	223.62
Long-Term Investments	-	128.67	22.95	12.2	54.32
Other Intangible Assets	-	104.97	110.43	93.03	28.12
Long-Term Deferred Tax Assets	-	22.2	30.18	46.44	3.82
Long-Term Deferred Charges	-	10.35	15.72	17.88	5.66
Other Long-Term Assets	-	51.1	15.53	18.96	24.62
Total Assets	-	4,186	4,116	4,695	4,008
Accounts Payable	-	104.8	77.61	171.17	360.65
Accrued Expenses	-	32.41	33.16	73.51	44.61
Current Portion of Leases	-	2.34	16.26	8.32	20.06
Current Income Taxes Payable	-	86.43	73.96	73.26	61.71
Current Unearned Revenue	-	40.84	41.62	147.2	226.27
Other Current Liabilities	-	32.37	31.56	37.29	0.91
Total Current Liabilities	-	299.19	274.16	510.75	714.2
Long-Term Leases	-	1.76	7.66	13.44	17.3
Long-Term Unearned Revenue	-	1.64	2.68	-	-
Long-Term Deferred Tax Liabilities	-	0.01	-	-	3.2
Total Liabilities	-	302.6	284.5	524.2	734.71
Common Stock	-	79.28	79.28	53.9	53.9
Additional Paid-In Capital	-	1,708	1,713	1,744	1,733
Retained Earnings	-	2,177	2,107	2,455	1,487
Treasury Stock	-	-113.01	-103.4	-115.56	-
Comprehensive Income & Other	-	32.5	30.75	28.39	0.26
Total Common Equity	3,902	3,884	3,827	4,166	3,274
Minority Interest	-	-0.22	4.31	4.4	-
Shareholders' Equity	3,901	3,883	3,832	4,171	3,274
Total Liabilities & Equity	-	4,186	4,116	4,695	4,008
Total Debt	8.25	4.1	23.91	21.77	37.36
Net Cash (Debt)	2,450	2,574	2,765	3,793	2,922
Net Cash Growth	-4.79%	-6.92%	-27.10%	29.80%	317.07%
Net Cash Per Share	30.87	32.50	34.91	47.86	39.07
Filing Date Shares Outstanding	79.24	77.87	77.53	78.24	79.78
Total Common Shares Outstanding	78.31	77.87	78.16	78.24	79.78
Working Capital	-	2,666	2,887	3,678	2,954
Book Value Per Share	49.83	49.87	48.97	53.25	41.03
Tangible Book Value	3,764	3,779	3,717	4,073	3,246
Tangible Book Value Per Share	48.06	48.53	47.56	52.06	40.68
Buildings	-	403.78	194.44	198.85	58.13
Machinery	-	117.42	113.61	91.69	58.93
Construction In Progress	-	459.92	488.25	42.3	82.37

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.